Literature DB >> 25543118

Hemispheric language asymmetry in first episode psychosis and schizotypy: the role of cannabis consumption and cognitive disorganization.

Daniela A Herzig1, Sarah Sullivan2, Glyn Lewis3, Rhiannon Corcoran4, Richard Drake5, Jonathan Evans2, David Nutt6, Christine Mohr7.   

Abstract

Cannabis use has been related to an elevated psychosis risk and attenuated cognitive functioning. Cannabis-related cognitive impairments are also observed in populations along the psychosis dimension. We here investigated whether a potential behavioral marker of the psychosis dimension (attenuated functional hemispheric asymmetry) is even further attenuated in individuals using cannabis (CU) vs those not using cannabis (nCU). We tested 29 patients with first-episode psychosis (FEP; 11 CU) and 90 healthy controls (38 CU) on lateralized lexical decisions assessing left-hemisphere language dominance. In patients, psychotic symptoms were assessed by Positive & Negative Symptom Scale (PANSS). In controls, self-reported schizotypy was assessed (The Oxford-Liverpool Inventory of Feelings and Experiences: O-LIFE). Results indicated that nCU FEP patients had a relative reduced hemispheric asymmetry, as did controls with increasing cognitive disorganization (CogDis) scores, in particular when belonging to the group of nCU controls. Positive, disorganized and negative PANSS scores in patients and negative and positive schizotypy in controls were unrelated to hemispheric asymmetry. These findings suggest that cannabis use potentially balances rather than exacerbates uncommon hemispheric laterality patterns. Moreover, in healthy populations, the potential stabilization of typical hemispheric asymmetry in CU might be most relevant to individuals with elevated CogDis. We discuss the potential beneficial and harmful effects of cannabis use along the psychosis dimension together with propositions for future studies that should account for the mediating role of additional substances (eg nicotine), cannabis composition (eg cannabidiol content), and individual differences (eg physical health, or absence of significant polysubstance use).
© The Author 2014. Published by Oxford University Press on behalf of the Maryland Psychiatric Research Center. All rights reserved. For permissions, please email: journals.permissions@oup.com.

Entities:  

Keywords:  cannabis; cognition; drugs; laterality; psychosis-proneness; schizotypy

Mesh:

Year:  2014        PMID: 25543118      PMCID: PMC4373630          DOI: 10.1093/schbul/sbu179

Source DB:  PubMed          Journal:  Schizophr Bull        ISSN: 0586-7614            Impact factor:   9.306


  71 in total

1.  Neuropsychological performance in long-term cannabis users.

Authors:  H G Pope; A J Gruber; J I Hudson; M A Huestis; D Yurgelun-Todd
Journal:  Arch Gen Psychiatry       Date:  2001-10

2.  Stressing schizotypy: the modulating role of stress-relieving behaviours and intellectual capacity on functional hemispheric asymmetry.

Authors:  Daniela A Herzig; Christine Mohr
Journal:  Laterality       Date:  2012-02-09

3.  Time course of tetrahydrocannabinol-induced changes in regional cerebral blood flow measured with positron emission tomography.

Authors:  Roy J Mathew; William H Wilson; Timothy G Turkington; Thomas C Hawk; R Edward Coleman; Timothy R DeGrado; James Provenzale
Journal:  Psychiatry Res       Date:  2002-12-30       Impact factor: 3.222

4.  Psychometric schizotypy modulates levodopa effects on lateralized lexical decision performance.

Authors:  Christine Mohr; Peter Krummenacher; Theodor Landis; Peter S Sandor; Marc Fathi; Peter Brugger
Journal:  J Psychiatr Res       Date:  2005-05       Impact factor: 4.791

5.  Effects of smoking marijuana on brain perfusion and cognition.

Authors:  Daniel S O'Leary; Robert I Block; Julie A Koeppel; Michael Flaum; Susan K Schultz; Nancy C Andreasen; Laura Boles Ponto; G Leonard Watkins; Richard R Hurtig; Richard D Hichwa
Journal:  Neuropsychopharmacology       Date:  2002-06       Impact factor: 7.853

6.  Sustained attention deficits in relation to psychometrically identified schizotypy: evaluating a potential endophenotypic marker.

Authors:  Diane C Gooding; Christie W Matts; Elizabeth A Rollmann
Journal:  Schizophr Res       Date:  2006-01-25       Impact factor: 4.939

7.  Neuroprotective effects of the nonpsychoactive cannabinoid cannabidiol in hypoxic-ischemic newborn piglets.

Authors:  Francisco J Alvarez; Hector Lafuente; M Carmen Rey-Santano; Victoria E Mielgo; Elena Gastiasoro; Miguel Rueda; Roger G Pertwee; Ana I Castillo; Julián Romero; José Martínez-Orgado
Journal:  Pediatr Res       Date:  2008-12       Impact factor: 3.756

Review 8.  Cannabis use and risk of psychotic or affective mental health outcomes: a systematic review.

Authors:  Theresa H M Moore; Stanley Zammit; Anne Lingford-Hughes; Thomas R E Barnes; Peter B Jones; Margaret Burke; Glyn Lewis
Journal:  Lancet       Date:  2007-07-28       Impact factor: 79.321

Review 9.  Cannabidiol as a potential treatment for psychosis.

Authors:  C D Schubart; I E C Sommer; P Fusar-Poli; L de Witte; R S Kahn; M P M Boks
Journal:  Eur Neuropsychopharmacol       Date:  2013-11-15       Impact factor: 4.600

10.  Alcohol and Relatively Pure Cannabis Use, but Not Schizotypy, are Associated with Cognitive Attenuations.

Authors:  Daniela A Herzig; David J Nutt; Christine Mohr
Journal:  Front Psychiatry       Date:  2014-09-29       Impact factor: 4.157

View more
  4 in total

1.  Integration and development in schizotypy research: an introduction to the special supplement.

Authors:  Martin Debbané; Christine Mohr
Journal:  Schizophr Bull       Date:  2015-03       Impact factor: 9.306

Review 2.  Cognition and brain function in schizotypy: a selective review.

Authors:  Ulrich Ettinger; Christine Mohr; Diane C Gooding; Alex S Cohen; Alexander Rapp; Corinna Haenschel; Sohee Park
Journal:  Schizophr Bull       Date:  2015-03       Impact factor: 9.306

Review 3.  Cannabis and Psychosis: a Critical Overview of the Relationship.

Authors:  Charles Ksir; Carl L Hart
Journal:  Curr Psychiatry Rep       Date:  2016-02       Impact factor: 5.285

Review 4.  Association between formal thought disorder and cannabis use: a systematic review and meta-analysis.

Authors:  Mathilde Argote; Guillaume Sescousse; Jérôme Brunelin; Eric Fakra; Mikail Nourredine; Benjamin Rolland
Journal:  Schizophrenia (Heidelb)       Date:  2022-09-29
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.